Panitumumab (Vectibix)

J.J. Gemmete; S.K. Mukherji

doi:10.3174/ajnr.A2601

Main menu

Home
Content
Special Collections
Multimedia
For Authors
About Us
- About AJNR
- Editorial Board
More

Other Publications
- ajnr

User menu

Alerts
Log in

Search

Search for this keyword

Advanced search

American Journal of Neuroradiology

Alerts
Log in

Search for this keyword

Advanced Search

Home
Content
Special Collections
Multimedia
For Authors
About Us
- About AJNR
- Editorial Board
More

Follow AJNR on Twitter
Visit AJNR on Facebook
Follow AJNR on Instagram
Join AJNR on LinkedIn
RSS Feeds

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.

AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

Research ArticlePharmacology Vignette

Panitumumab (Vectibix)

J.J. Gemmete and S.K. Mukherji

American Journal of Neuroradiology June 2011, 32 (6) 1002-1003; DOI: https://doi.org/10.3174/ajnr.A2601

J.J. Gemmete

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

S.K. Mukherji

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
Responses
References
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

American Journal of Neuroradiology

Vol. 32, Issue 6

1 Jun 2011

Table of Contents
Index by author

Download PDF

Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Panitumumab (Vectibix)

Message Subject (Your Name) has sent you a message from American Journal of Neuroradiology

Message Body (Your Name) thought you would like to see the American Journal of Neuroradiology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cite this article

J.J. Gemmete, S.K. Mukherji

Panitumumab (Vectibix)

American Journal of Neuroradiology Jun 2011, 32 (6) 1002-1003; DOI: 10.3174/ajnr.A2601

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

0 Responses

Respond to this article

Bookmark this article

User Name *

Password *

Remember my user name & password.

Panitumumab (Vectibix)

J.J. Gemmete, S.K. Mukherji

American Journal of Neuroradiology Jun 2011, 32 (6) 1002-1003; DOI: 10.3174/ajnr.A2601

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Purchase

Jump to section

Article
Figures & Data
Info & Metrics
Responses
References
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations

Crossref (21)
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Oxidative Stress in Cancer Cell Metabolism

Saniya Arfin, Niraj Kumar Jha, Saurabh Kumar Jha, Kavindra Kumar Kesari, Janne Ruokolainen, Shubhadeep Roychoudhury, Brijesh Rathi, Dhruv Kumar

Antioxidants 2021 10 5
How to select IgG subclasses in developing anti-tumor therapeutic antibodies

Jifeng Yu, Yongping Song, Wenzhi Tian

Journal of Hematology & Oncology 2020 13 1
Antibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor Family in Cancers

Jinfeng Yu, Tong Fang, Chengyu Yun, Xue Liu, Xiaoqing Cai

Frontiers in Molecular Biosciences 2022 9
Anticancer therapy and lung injury: molecular mechanisms

Li Li, Henry Mok, Pavan Jhaveri, Mark D Bonnen, Andrew G Sikora, N. Tony Eissa, Ritsuko U Komaki, Yohannes T Ghebre

Expert Review of Anticancer Therapy 2018 18 10
Nanocell targeting using engineered bispecific antibodies

Karin Taylor, Christopher B Howard, Martina L Jones, Ilya Sedliarou, Jennifer MacDiarmid, Himanshu Brahmbhatt, Trent P Munro, Stephen M Mahler

mAbs 2015 7 1
Recombinant Antibody Engineering Enables Reversible Binding for Continuous Protein Biosensing

Christian Fercher, Martina L. Jones, Stephen M. Mahler, Simon R. Corrie

ACS Sensors 2021 6 3
Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities

Shawyon Ezzati, Samuel Salib, Meenakshisundaram Balasubramaniam, Orwa Aboud

International Journal of Molecular Sciences 2024 25 4
Cellular and molecular properties of 90Y-labeled cetuximab in combination with radiotherapy on human tumor cells in vitro

M. Saki, M. Toulany, W. Sihver, M. Zenker, J.-M. Heldt, B. Mosch, H.-J. Pietzsch, M. Baumann, J. Steinbach, H.P. Rodemann

Strahlentherapie und Onkologie 2012 188 9
A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way

Pankti C. Balar, Vasso Apostolopoulos, Vivek P. Chavda

European Journal of Pharmacology 2024 969
Immuno-PET Imaging of EGFR with 64Cu-NOTA Panitumumab in Subcutaneous and Metastatic Nonsmall Cell Lung Cancer Xenografts

Nasim Sarrami, Melinda Wuest, Igor Moura de Paiva, Samantha Leier, Afsaneh Lavasanifar, Frank Wuest

Molecular Pharmaceutics 2024 21 11

Indexed Content

Current Issue
Accepted Manuscripts
Article Preview
Past Issues
Editorials
Editors Choice
Fellow Journal Club
Letters to the Editor

Cases

Case Collection
Archive - Case of the Week
Archive - Case of the Month
Archive - Classic Case

Special Collections

Special Collections

Resources

News and Updates
Turn around Times
Submit a Manuscript
Author Policies
Manuscript Submission Guidelines
Evidence-Based Medicine Level Guide
Publishing Checklists
Graphical Abstract Preparation
Imaging Protocol Submission
Submit a Case
Become a Reviewer/Academy of Reviewers
Get Peer Review Credit from Publons

Multimedia

AJNR Podcast
AJNR SCANtastic
Video Articles

About Us

About AJNR
Editorial Board
Not an AJNR Subscriber? Join Now
Alerts
Feedback
Advertise with us
Librarian Resources
Permissions
Terms and Conditions

American Society of Neuroradiology

Not an ASNR Member? Join Now

Main menu

User menu

Search

American Journal of Neuroradiology

Panitumumab (Vectibix)

Plain text

Vertical Tabs

Jump to comment:

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Indexed Content

Cases

Special Collections

Resources

Multimedia

About Us

American Society of Neuroradiology